How Is MCAS Diagnosed? Criteria, Testing, and Why It Takes So Long

The most common thing I hear about mast cell activation syndrome is some version of: I know something is wrong, but every test comes back normal.

That is not a failure of your body or of your prior clinicians. It is a reflection of how this diagnosis is built. There is no single blood test for MCAS. It is a criteria-based diagnosis, and the criteria depend on how and when the testing is done.

If you are new to the condition itself, start with my MCAS primer. This piece is about the workup.

---

The three consensus criteria

The widely used consensus framework requires all three of the following:

1. Episodic symptoms in two or more organ systems. Skin, gastrointestinal, cardiovascular, respiratory, or neurologic. The pattern is episodic — flares and recovery — rather than a flat, constant baseline.

2. Objective evidence of mast cell mediator release. Most commonly a rise in serum tryptase during an episode compared with your own baseline. Other mediators can be used when tryptase is unrevealing.

3. Symptom improvement with mast-cell-directed therapy. Antihistamines and stabilizers. This is a real criterion, not a formality.

Meeting one or two of these is common. Meeting all three is what supports the diagnosis, and the second one is where most workups stall.

---

Why tryptase confuses everyone

Serum tryptase is the most useful single marker, and it is also the most misunderstood.

• Baseline tryptase is usually normal in MCAS. A normal value does not rule it out. It rules out other mast cell disorders, which is a different question.
• The comparison that matters is a delta. The commonly used threshold is an acute level that rises above 20 percent of baseline plus 2 ng/mL during a flare.
• Timing is narrow. The acute sample is drawn roughly 30 minutes to 2 hours after symptoms begin. A sample taken the next day tells you nothing.
• A persistently elevated baseline points toward systemic mastocytosis or hereditary alpha tryptasemia, both of which change the plan.

This is why so many patients are told their tryptase was fine. The value was fine — but it was drawn on a calm day, which was never going to answer the question.

---

Other mediators and their limits

When tryptase is unhelpful, other mediators may be checked:

• N-methylhistamine, 24-hour urine
• Prostaglandin D2 metabolites, such as 11-beta-prostaglandin F2-alpha
• Leukotriene E4, urine
• Plasma histamine, which is highly time-sensitive

Each of these has practical problems. Diet, common medications, and collection technique all move the results, and normal values do not exclude the diagnosis.

Handling ruins more of these tests than anything else. Most require immediate chilling, transport on ice, and prompt processing. If a specimen sits at room temperature, the result is meaningless — not negative, meaningless. When I order these, I write out the collection instructions and confirm the lab can handle them, because a mishandled panel costs you months.

---

What has to be considered first

Before MCAS becomes the working diagnosis, other explanations for flushing, diarrhea, tachycardia, and syncope deserve honest consideration:

• Carcinoid syndrome
• Pheochromocytoma
• Systemic mastocytosis
• Hereditary alpha tryptasemia
• Thyroid disease, including hyperthyroidism
• IgE-mediated allergy and hereditary angioedema
• Histamine intolerance, which overlaps in symptoms but is a different mechanism
• Medication effects, including opioids, NSAIDs, vancomycin, and contrast agents

Ruling these out is not gatekeeping. Two of them are treatable in entirely different ways, and missing them matters.

---

What does not diagnose MCAS

• Food sensitivity IgG panels
• Hair, saliva, or stool "inflammation" panels
• Symptom questionnaires used alone
• A positive response to an antihistamine by itself
• Genetic panels marketed direct to consumers

A questionnaire is a good place to organize your history. It is not evidence of mediator release.

---

Why it takes years

Three structural reasons, and none of them are your fault.

The symptoms cross specialty lines, so allergy, gastroenterology, cardiology, and neurology each see one slice. The testing is time-locked to flares, and flares rarely happen inside a lab's business hours. And the condition frequently travels with POTS and hypermobility, which fragments care further.

---

How I run the workup

I take a detailed episode history first — what happens, in what order, how long it lasts, and what reliably provokes it. That history determines which tests are worth drawing and when.

Then I order the right panel with explicit collection instructions, screen for the conditions above, and check the things that commonly sit underneath a stalled case: ferritin, thyroid, and orthostatic vitals.

If the criteria are met, we move to the stepwise plan in MCAS treatment: what actually helps. If they are not, that is still useful information, and it usually points somewhere specific rather than nowhere.

A diagnosis you cannot confirm on one lab draw is not the same as a diagnosis nobody can make. It takes a clinician willing to run the process in the right order.